Search results
Author(s):
Rik Rozemeijer
,
Wijnand P van Bezouwen
,
Michiel Voskuil
,
et al
Added:
3 years ago
Dual antiplatelet therapy (DAPT) consisting of aspirin and a P2Y12 inhibitor is prescribed in the treatment of acute coronary syndrome (ACS) or following percutaneous coronary intervention (PCI) for drug-eluting stent (DES) implantation. An important misconception remains that DAPT should be prescribed to prevent stent thrombosis. Although this may seem obvious, it should be emphasized that the…
View more
Author(s):
Xiaoyu Yang
,
Mohamed Ahmed
,
Donald E Cutlip
Added:
3 years ago
Over the past 35 years, treatment of coronary artery disease and acute coronary syndrome has changed drastically. Balloon angioplasty offered an early mechanical solution but carried a high risk for acute complications and subsequent restenosis, mainly from recoil. The bare metal stent (BMS) improved restenosis because of recoil, but still carried a relatively high rate of restenosis because of…
View more
Author(s):
Christopher J White
Added:
3 years ago
More than three-quarters of a million Americans will suffer a stroke this year. Stroke ranks as the third most common cause of death after heart disease and cancer. It is the number one cause of disability among adults and the main reason for rehabilitation. Many, but not all, strokes are related to atherosclerosisÔÇöthe same disease that causes heart attacks. Blockage of one of the two main…
View more
PCI in Women
Author(s):
Mirvat Alasnag
,
Valeria Paradies
,
Nicola Ryan
,
et al
Added:
4 months ago
Article
Author(s):
Johny Nicolas
,
Usman Baber
,
Roxana Mehran
Added:
3 years ago
Seminal clinical trials conducted in the balloon angioplasty and bare metal stent era established the superiority of dual antiplatelet therapy (DAPT) as compared with aspirin monotherapy or anticoagulation with respect to the prevention of thrombotic events.1,2 Other studies found that the benefits of DAPT are durable for at least 1 year and extend to patients with acute coronary syndromes.3–5…
View more
Author(s):
Ali Nazmi Calik
,
F Aaysha Cader
,
Erik Rafflenbeul
,
et al
Added:
7 months ago
Author(s):
Quynh Nguyen
,
Jessica GY Luc
,
Thomas E MacGillivray
,
et al
Added:
1 year ago
Antithrombotics in TAVR
Author(s):
Mathew R Williams
,
Kelsey Grossman
,
Homam Ibrahim
Added:
3 years ago
Article
Author(s):
Joost Daemen
,
Nicolas M Van Mieghem
Added:
5 months ago
What's hot at TCT 2023?
In this episode of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcenter, Erasmus MC, NL) preview the late-breaking data presented at TCT 2023.
With their dynamic analysis, these anticipated trials are placed in context, highlighting the real-world implications tied to the data releases.
Top trials covered:
00:31 - 02:12: PARTNER 3 Low…
View more
Author(s):
Jimmy Kerrigan
,
Timir K Paul
,
Jay Patel
,
et al
Added:
5 months ago